Metronom Continuous Glucose Monitoring System

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The aim of the present study is to investigate the clinical performance of the Metronom CGM system in patients with type 1 diabetes over a period of 14 days. In this study, the CGM sensor will be tested in an inpatient setting (meal/insulin test with frequent plasma glucose monitoring) at different days of wear-time. Sensor data will be compared to gold standard reference (Super GL2 analyser or YSI) and stability of sensor performance will be assessed over time. Additionally, safety and tolerability of the sensor will be investigated by regular assessment of the insertion site.
Epistemonikos ID: e176b7e27393e13537c6a76b4a60eb5808608a90
First added on: May 21, 2024